Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

Abstract Background Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate the relationship between the levels of serum FGF19...

Full description

Bibliographic Details
Main Authors: Meng-jie Tang, Jian‑bin Su, Tian-li Xu, Xue‑qin Wang, Dong-mei Zhang, Xiao-hua Wang
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Islet beta cell function
Insulin sensitivity
FGF19
Type 2 diabetes
Online Access:http://link.springer.com/article/10.1186/s13098-019-0475-1

Internet

http://link.springer.com/article/10.1186/s13098-019-0475-1

Similar Items